Inhibited, trapped or adducted: the optimal selective synthetic lethal mix for BRCAness

Ann Oncol. 2018 Jan 1;29(1):18-21. doi: 10.1093/annonc/mdx775.
No abstract available

Publication types

  • Comment

MeSH terms

  • Benzimidazoles
  • Breast Neoplasms*
  • Carboplatin
  • Humans
  • Neoplasm Recurrence, Local
  • Paclitaxel
  • Temozolomide

Substances

  • Benzimidazoles
  • veliparib
  • Carboplatin
  • Paclitaxel
  • Temozolomide